Recently, Dorayshield successfully exported five sets of tungsten alloy vial shields and ten 3cc tungsten alloy syringe shields to a medical equipment supplier in Morocco, marking the official entry of the company's radiation protection products into the Northwest African market.
In the nuclear medicine field, the tungsten alloy vial shields, along with the 3cc tungsten alloy syringe shields, comprise essential protective tools. The former can be used to store and transport radio-pharmaceuticals, and the containers are made with a high-density tungsten alloy which possesses excellent radiation blocking characteristics. This means that hazardous radioactive material can be contained, and a safe storage environment is maintained. The latter shields medical personnel from scattered radiation and is used during the injection of radio-pharmaceuticals, thereby protecting the staff from excessive radiation during the procedure. In Morocco, the healthcare system is gradually improving with new nuclear medicine equipment. Since they are the first to demand quality protective nuclear medicine equipment, suppliers are accustomed to the suppliers meeting the performance, stability, and regulatory expectations of the equipment. Dorayshield is also focused on performance, from the selection of the raw materials to the production of the equipment, which meets the medical grade shielding standards of high-density tungsten alloys, to precision machining that guarantees the seal of shielding canisters and the injection shields.
This order is the result of Dorayshield's long-term commitment to the medical radiation protection sector and its expansion into overseas markets. In recent years, the company has consistently prioritized "protecting medical radiation safety" and continuously optimized its product designs. The company has refined the specifications and functionality of its shielding equipment to meet the specific medical needs of different countries (for example, the 3cc syringe shield is a customized product suitable for small-dose medication injections). Furthermore, the company has established an efficient foreign trade service system, thoroughly researching medical device certification standards in various countries, and providing customers with comprehensive support from product selection to regulatory compliance filings. Dorayshield's protective products have already entered the medical markets of numerous countries, and this expansion into Morocco further expands the company's presence in the African medical radiation protection sector.
For Dorayshield, this export to Morocco represents more than just a successful order; it also opens a new market entry into the North African medical protection market. Going forward, the company will leverage this partnership to continuously focus on the development needs of the medical industry in Morocco and North Africa, increasing investment in product research and development and customization capabilities. Furthermore, the company will deepen its overseas channel development, promote the global distribution of high-quality medical radiation protection products, contribute to global medical radiation safety, and achieve even higher-quality growth in its foreign trade business.
